Novavax says it has resolved the manufacturing problems that delayed U.S. authorization of its Covid-19 vaccine. Health regulators have begun their review.
Company says it has resolved manufacturing problems that led to earlier delays; FDA is reviewing shot’s authorization application| Photographs by Shuran Huang for The Wall Street JournalNovavax Inc.’s long-awaited Covid-19 vaccine is moving toward U.S.
authorization after the company said it resolvedClearance in the U.S. isn’t imminent because the Food and Drug Administration must sort through a large amount of study data from several countries, a person familiar with the matter said. A decision is getting closer, however, since Novavax formally submitted an authorization request in late January.
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Three Covid-related deaths and 1,991 casesThe total number of deaths linked to the virus reported by Stormont's Department of Health is 3,226.
Read more »
LA County Lifts Indoor Mask Mandate After Being Reclassified As Having 'Low' COVID-19 ActivityMasking in most indoor public spaces -- such as restaurants, movie theaters, gyms, retail stores and nail salons -- will no longer be required regardless of vaccination status.
Read more »
Exercise after COVID-19 vaccine may increase antibodies, study findsThe study demonstrates that 90 minutes of exercise after immunization of the COVID-19 vaccine increases antibody response several weeks later.
Read more »
Covid-19: Nisra records 33 deaths in past week in Northern IrelandThe virus was mentioned on the death certificates of 33 people in the week up to 25 February, Nisra says.
Read more »